Effect of 3200 MHz Radiofrequency Fields on MCF-7 and L929 Cell Lines
Abstract
Objective: The use of technological devices emitting radio frequency fields(RFF) is increasing day by day. Nowadays, low-frequency RFF has begun to be used in cancer treatment as a non-invasive method. However, the time-dependent effects of high-frequency RFF on healthy and cancer cells are not yet clear. This study aims to examine the time-dependent effects of 3200MHz RFF on human breast cancer (MCF-7) and healthy mouse fibroblast (L929) cell lines.
Methods: MCF-7 and L929 cells were cultured with DMEM medium. RFF exposures were applied at 29.55dBm power levels (with Efield level 14V/m). MCF-7 and L929 cell lines were exposed to 3200 MHz RFF for 4 hours. Cell viability levels were determined immediately after exposure and following a 2-hour post-exposure incubation period.
Results: Immediately after 4 hours of 3200 MHz RFF exposure, cell viability decreased significantly by 12% in MCF-7 cells, with a further 15% decrease observed after a 2-hour post-exposure period. In contrast, the L929 cell line exhibited a significant increase in viability, with levels rising by 27% immediately after exposure and by 16% following the 2-hour post-exposure period(p<0.0001).
Conclusions: The results of this study suggest that 3200MHz RFF exposure has a significant effect on the viability levels of cancer cells and that 3200MHz RFF can create the effect that low-frequency fields currently used as a non-invasive method have with a significant temperature increase, without a temperature increase. It is also effective in increasing healthy fibroblast cells, suggesting that it can be used as an alternative method to wound healing and cell renewal treatments.
Keywords
References
- Ziegelberger G, Croft R, Feychting M, et al. Guidelines for limiting exposure to electromagnetic fields (100 kHz to 300 GHz). Health Phys. 2020;118(5):483-524. doi:10.1097/HP.0000000000001210.
- Iarc W. IARC Classifies radiofrequency electromagnetic fields as possibly cancinogenic to humans. International Agency for Research on Cancer. 2011.
- Marjanović A-M, Pavičić I, Trošić I. Biological indicators in response to radiofrequency/microwave exposure. Arh Hig Rada Toksikol. 2012;63(3):407-15. doi:10.2478/10004-1254-63-2012-2215.
- Yakymenko I, Tsybulin O, Sidorik E, Henshel D, Kyrylenko O, Kyrylenko S. Oxidative mechanisms of biological activity of low-intensity radiofrequency radiation. Electromagn Biol Med. 2016;35(2):186-202. doi:10.3109/15368378.2015.1043557.
- McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25(3):267-70. doi:10.1097/00004424-199003000-00011.
- Rossi S, Fornati F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 1990;76(1):54-7. doi:10.1177/030089169007600114.
- Glazer ES, Zhu C, Massey KL, Thompson CS, Kaluarachchi WD, Hamir AN, et al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin Cancer Res. 2010;16(23):5712-21. doi:10.1158/1078-0432.CCR-10-2055.
- Ripley RT, Gajdos C, Reppert AE, MacDermott T, McCarter MD, Pearlman NW. Sequential radiofrequency ablation and surgical debulking for unresectable colorectal carcinoma: Thermo‐surgical ablation. J Surg Oncol. 2013;107(2):144-7. doi:10.1002/jso.23211.
Details
Primary Language
English
Subjects
Clinical Sciences (Other)
Journal Section
Research Article
Authors
Sevilay Günay
0000-0002-0130-5629
Türkiye
Kayhan Ateş
0000-0002-6016-6577
Türkiye
Yavuz Erden
0000-0002-2807-6096
Türkiye
Early Pub Date
September 27, 2026
Publication Date
September 30, 2026
Submission Date
April 27, 2026
Acceptance Date
September 1, 2026
Published in Issue
Year 2026 Volume: 16 Number: 3